AAAAAA
Results:
1-14
|
Results: 14
Authors:
Lajic, S
Robins, T
Krone, N
Schwarz, HP
Wedell, A
Citation: S. Lajic et al., CYP21 mutations in simple virilizing congenital adrenal hyperplasia, J MOL MED-J, 79(10), 2001, pp. 581-586
Authors:
Enberg, U
Farnebo, LO
Wedell, A
Grondal, S
Thoren, M
Grimelius, L
Kjellman, M
Backdahl, M
Hamberger, B
Citation: U. Enberg et al., In vitro release of aldosterone and cortisol in human adrenal adenomas correlates to mRNA expression of steroidogenic enzymes for genes CYP11B2 and CYP17, WORLD J SUR, 25(7), 2001, pp. 957-966
Authors:
Giwercman, YL
Nikoshkov, A
Bystrom, B
Pousette, A
Arver, S
Wedell, A
Citation: Yl. Giwercman et al., A novel mutation (N233K) in the transactivating domain and the N756S mutation in the ligand binding domain of the androgen receptor gene are associated with male infertility, CLIN ENDOCR, 54(6), 2001, pp. 827-834
Authors:
Nordenstrom, A
Wedell, A
Hagenfeldt, L
Marcus, C
Larsson, A
Citation: A. Nordenstrom et al., Neonatal screening for congenital adrenal hyperplasia: 17-hydroxyprogesterone levels and CYP21 genotypes in preterm infants, PEDIATRICS, 108(4), 2001, pp. NIL_66-NIL_73
Authors:
Nordenstrom, A
Marcus, C
Axelson, M
Wedell, A
Ritzen, M
Citation: A. Nordenstrom et al., Defective 11 beta-HSD reductase activity in a patient with congenital adrenal hyperplasia, J CLIN END, 86(3), 2001, pp. 1426-1427
Authors:
Giwercman, YL
Nikoshkov, A
Lindsten, K
Bystrom, B
Pousette, A
Knudtzon, J
Alm, J
Wedell, A
Citation: Yl. Giwercman et al., Response to treatment in patients with partial androgen insensitivity due to mutations in the DNA-binding domain of the androgen receptor, HORMONE RES, 53(2), 2000, pp. 83-88
Authors:
Ritzen, EM
Lajic, S
Wedell, A
Citation: Em. Ritzen et al., How can molecular biology contribute to the management of congenital adrenal hyperplasia?, HORMONE RES, 53, 2000, pp. 34-37
Authors:
Giwercman, A
Kledal, T
Schwartz, M
Giwercman, YL
Leffers, H
Zazzi, H
Wedell, A
Skakkebaek, NE
Citation: A. Giwercman et al., Preserved male fertility despite decreased androgen sensitivity caused by a mutation in the ligand-binding domain of the androgen receptor gene, J CLIN END, 85(6), 2000, pp. 2253-2259
Authors:
Kjellman, M
Holst, M
Backdahl, M
Larsson, C
Farnebo, LO
Wedell, A
Citation: M. Kjellman et al., No overrepresentation of congenital adrenal hyperplasia in patients with adrenocortical tumours, CLIN ENDOCR, 50(3), 1999, pp. 343-346
Authors:
Nikoshkov, A
Falorni, A
Lajic, S
Laureti, S
Wedell, A
Lernmark, A
Luthman, H
Citation: A. Nikoshkov et al., A conformation-dependent epitope in Addison's disease and other endocrinological autoimmune diseases maps to a carboxyl-terminal functional domain ofhuman steroid 21-hydroxylase, J IMMUNOL, 162(4), 1999, pp. 2422-2426
Authors:
Nordenstrom, A
Thilen, A
Hagenfeldt, L
Larsson, A
Wedell, A
Citation: A. Nordenstrom et al., Genotyping is a valuable diagnostic complement to neonatal screening for congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency, J CLIN END, 84(5), 1999, pp. 1505-1509
Authors:
Nordenstrom, A
Marcus, C
Axelson, M
Wedell, A
Ritzen, EM
Citation: A. Nordenstrom et al., Failure of cortisone acetate treatment in congenital adrenal hyperplasia because of defective 11 beta-hydroxysteroid dehydrogenase reductase activity, J CLIN END, 84(4), 1999, pp. 1210-1213
Authors:
Lajic, S
Nikoshkov, A
Holst, M
Wedell, A
Citation: S. Lajic et al., Effects of missense mutations and deletions on membrane anchoring and enzyme function of human steroid 21-hydroxylase (P450c21), BIOC BIOP R, 257(2), 1999, pp. 384-390
Authors:
Giwercman, YL
Nikoshkov, A
Lindsten, K
Bystrom, B
Pousette, A
Chibalin, AV
Arvidsson, S
Tiulpakov, A
Semitcheva, TV
Peterkova, V
Hagenfeldt, K
Ritzen, EM
Wedell, A
Citation: Yl. Giwercman et al., Functional characterisation of mutations in the ligand-binding domain of the androgen receptor gene in patients with androgen insensitivity syndrome, HUM GENET, 103(4), 1998, pp. 529-531
Risultati:
1-14
|